TCI Wealth Advisors Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,609 shares of the healthcare conglomerate’s stock after acquiring an additional 23 shares during the period. TCI Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $298,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $110,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its holdings in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $121,000. Kings Point Capital Management grew its holdings in shares of UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after acquiring an additional 150 shares during the period. Finally, Jacobi Capital Management LLC grew its holdings in shares of UnitedHealth Group by 6.6% in the 2nd quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock worth $136,000 after acquiring an additional 45 shares during the period. Institutional investors and hedge funds own 85.71% of the company’s stock.
UnitedHealth Group Incorporated (UNH) opened at $212.60 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market capitalization of $205,550.00, a price-to-earnings ratio of 21.86, a P/E/G ratio of 1.56 and a beta of 0.64. UnitedHealth Group Incorporated has a 52-week low of $150.00 and a 52-week high of $213.93.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the company posted $2.17 EPS. The business’s quarterly revenue was up 8.7% on a year-over-year basis. analysts predict that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders sold 57,606 shares of company stock worth $11,433,133 over the last three months. 0.89% of the stock is currently owned by corporate insiders.
UNH has been the topic of a number of analyst reports. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Credit Suisse Group initiated coverage on UnitedHealth Group in a report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 target price on the stock. Mizuho reiterated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, October 24th. Oppenheimer Holdings, Inc. increased their target price on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a report on Wednesday, October 18th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $219.00 target price (up previously from $210.00) on shares of UnitedHealth Group in a report on Thursday, October 19th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $216.65.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.